Your browser doesn't support javascript.
loading
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Kappos, Ludwig; Wiendl, Heinz; Selmaj, Krzysztof; Arnold, Douglas L; Havrdova, Eva; Boyko, Alexey; Kaufman, Michael; Rose, John; Greenberg, Steven; Sweetser, Marianne; Riester, Katherine; O'Neill, Gilmore; Elkins, Jacob.
  • Kappos L; From the Neurologic Clinic and Policlinic, the Departments of Medicine, Clinical Research, and Biomedicine and Biomedical Engineering, University Hospital, Basel, Switzerland (L.K.); the Department of Neurology, University of Münster, Münster, Germany (H.W.); the Department of Neurology, Medical University of Lodz, Lodz, Poland (K.S.); NeuroRx Research and Montreal Neurological Institute, McGill University - both in Montreal (D.L.A.); the Department of Neurology, First Faculty of Medicine, Charl
N Engl J Med ; 373(15): 1418-28, 2015 Oct 08.
Article en En | MEDLINE | ID: mdl-26444729
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina G / Adyuvantes Inmunológicos / Interferón beta / Esclerosis Múltiple Recurrente-Remitente / Anticuerpos Monoclonales Humanizados / Inmunosupresores Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina G / Adyuvantes Inmunológicos / Interferón beta / Esclerosis Múltiple Recurrente-Remitente / Anticuerpos Monoclonales Humanizados / Inmunosupresores Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article